Published in Curr Urol Rep on October 01, 2012
Neuromodulation for overactive bladder. Nat Rev Urol (2013) 0.87
Impact of Bioelectronic Medicine on the Neural Regulation of Pelvic Visceral Function. Bioelectron Med (2015) 0.79
Electrical stimulation for the treatment of lower urinary tract dysfunction after spinal cord injury. J Spinal Cord Med (2015) 0.76
Posterior tibial nerve stimulation for fecal incontinence: where are we? World J Gastroenterol (2013) 0.76
Neuromodulation in male chronic pelvic pain syndrome: rationale and practice. World J Urol (2013) 0.75
Tibial nerve stimulation with a miniature, wireless stimulator in chronic peripheral neuropathic pain. J Pain Res (2017) 0.75
Posterior tibial nerve stimulation as treatment for the overactive bladder. Arab J Urol (2013) 0.75
Clinical utility of neurostimulation devices in the treatment of overactive bladder: current perspectives. Med Devices (Auckl) (2017) 0.75
Prevalence and burden of overactive bladder in the United States. World J Urol (2002) 7.33
How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int (2001) 5.10
Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol (2003) 4.45
Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol (2010) 3.26
Economic costs of overactive bladder in the United States. Urology (2009) 2.68
Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol (2009) 2.06
The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol (2005) 2.02
Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol (1999) 1.88
Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. Neurourol Urodyn (2003) 1.78
The placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms. Eur Urol (2006) 1.61
Clinical practice. Idiopathic urgency urinary incontinence. N Engl J Med (2010) 1.61
Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol (2010) 1.42
Comorbidities associated with overactive bladder. Am J Manag Care (2000) 1.41
Treatment of overactive bladder in women. Evid Rep Technol Assess (Full Rep) (2009) 1.41
Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol (1983) 1.40
Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. Urology (2003) 1.37
Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol (2001) 1.36
The effects of somatic stimuli on the bladder in the cat. J Physiol (1966) 1.33
National trends in the usage and success of sacral nerve test stimulation. J Urol (2011) 1.27
Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial. J Urol (2010) 1.26
Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis. Neurourol Urodyn (2012) 1.24
Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. Cochrane Database Syst Rev (2009) 1.22
Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach. PLoS One (2011) 1.16
Prolonged poststimulation inhibition of bladder activity induced by tibial nerve stimulation in cats. Am J Physiol Renal Physiol (2010) 1.11
Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms. Obstet Gynecol (2008) 1.07
Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology (2000) 1.03
The effects of antimuscarinics on health-related quality of life in overactive bladder: a systematic review and meta-analysis. Urology (2006) 1.00
Control of reflex detrusor activity in normal and spinal injured non-human primates. J Urol (1983) 0.97
Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder. Urology (2010) 0.93
Posterior tibial nerve stimulation in the treatment of voiding dysfunction: urodynamic data. Neurourol Urodyn (2004) 0.88
Redefining response in overactive bladder syndrome. BJU Int (2007) 0.84
The relationship between subjective and objective assessments of sacral neuromodulation effectiveness in patients with urgency-frequency. Neurourol Urodyn (2008) 0.82
Somato-vesical reflexes in chronic spinal cats. J Auton Nerv Syst (1983) 0.80
Percutaneous tibial nerve stimulation for the treatment of urinary frequency, urinary urgency, and urge incontinence: results from a community-based clinic. Urol Nurs (2009) 0.78
Vesico-somatic reflexes in the chronic spinal cat. J Physiol (1966) 0.77
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet (2011) 11.28
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. Lancet (2011) 8.81
The neural control of micturition. Nat Rev Neurosci (2008) 4.19
Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyses by baseline prostate-specific antigen doubling time. J Clin Oncol (2013) 2.52
Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device. Sci Transl Med (2012) 2.17
Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat Clin Pract Urol (2007) 2.06
Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation. J Urol (2012) 2.01
Interstitial cystitis-is it time to look beyond the bladder? J Urol (2011) 2.00
Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn (2011) 1.93
Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis. J Urol (2012) 1.75
An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients. J Urol (2003) 1.73
Inhibition of bladder overactivity by a combination of tibial neuromodulation and tramadol treatment in cats. Am J Physiol Renal Physiol (2012) 1.65
Pudendal-to-bladder reflex in chronic spinal-cord-injured cats. Exp Neurol (2005) 1.63
Pannexin 1 channels mediate the release of ATP into the lumen of the rat urinary bladder. J Physiol (2015) 1.59
Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells. J Neurosci (2002) 1.58
An HSV vector system for selection of ligand-gated ion channel modulators. Nat Methods (2007) 1.57
The role of capsaicin-sensitive afferent fibers in the lower urinary tract dysfunction induced by chronic spinal cord injury in rats. Exp Neurol (2004) 1.54
A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J Urol (2005) 1.54
Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms. Eur Urol (2013) 1.54
Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial. Lancet Oncol (2013) 1.51
Block of external urethral sphincter contraction by high frequency electrical stimulation of pudendal nerve. J Urol (2004) 1.51
Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats. J Neurosci (2006) 1.48
Bladder Adelta afferent nerve activity in normal cats and cats with feline interstitial cystitis. J Urol (2005) 1.48
Changes in dopaminergic and glutamatergic excitatory mechanisms of micturition reflex after middle cerebral artery occlusion in conscious rats. Exp Neurol (2002) 1.48
Effect of (+/-)-epibatidine, a nicotinic agonist, on the central pathways controlling voiding function in the rat. Am J Physiol Regul Integr Comp Physiol (2003) 1.47
Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium. Neurourol Urodyn (2013) 1.46
Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol (2009) 1.45
Bladder inhibition or voiding induced by pudendal nerve stimulation in chronic spinal cord injured cats. Neurourol Urodyn (2007) 1.43
Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol (2010) 1.42
Expression of functional nicotinic acetylcholine receptors in rat urinary bladder epithelial cells. Am J Physiol Renal Physiol (2005) 1.42
Immunoneutralization of nerve growth factor in lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats. J Urol (2002) 1.41
Simulation analysis of conduction block in unmyelinated axons induced by high-frequency biphasic electrical currents. IEEE Trans Biomed Eng (2005) 1.40
Secondary changes in bowel function after successful treatment of voiding symptoms with neuromodulation. Neurourol Urodyn (2010) 1.40
Differential role of opioid receptors in tibial nerve inhibition of nociceptive and nonnociceptive bladder reflexes in cats. Am J Physiol Renal Physiol (2012) 1.38
Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol (2005) 1.33
Simulation of nerve block by high-frequency sinusoidal electrical current based on the Hodgkin-Huxley model. IEEE Trans Neural Syst Rehabil Eng (2005) 1.33
External urethral sphincter activity in a rat model of pudendal nerve injury. Neurourol Urodyn (2006) 1.32
Urethral closure mechanisms under sneeze-induced stress condition in rats: a new animal model for evaluation of stress urinary incontinence. Am J Physiol Regul Integr Comp Physiol (2003) 1.32
The role of bladder-to-urethral reflexes in urinary continence mechanisms in rats. Am J Physiol Renal Physiol (2004) 1.29
Non-neuronal acetylcholine and urinary bladder urothelium. Life Sci (2007) 1.27
Activation of muscarinic receptors in rat bladder sensory pathways alters reflex bladder activity. J Neurosci (2008) 1.26
Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium. J Physiol (2004) 1.26
Inhibitory and excitatory perigenital-to-bladder spinal reflexes in the cat. Am J Physiol Renal Physiol (2007) 1.25
Autonomic nerve stimulation reverses ventricular repolarization sequence in rabbit hearts. Circ Res (2007) 1.22
Serotonergic drugs and spinal cord transections indicate that different spinal circuits are involved in external urethral sphincter activity in rats. Am J Physiol Renal Physiol (2006) 1.22
Developmental changes in spontaneous smooth muscle activity in the neonatal rat urinary bladder. Am J Physiol Regul Integr Comp Physiol (2003) 1.21
Suppression of bladder overactivity by activation of somatic afferent nerves in the foot. BJU Int (2011) 1.21
Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats. Am J Physiol Renal Physiol (2008) 1.20
Identification of c-kit-positive cells in the mouse ureter: the interstitial cells of Cajal of the urinary tract. Am J Physiol Renal Physiol (2003) 1.19
Role of noradrenergic pathways in sneeze-induced urethral continence reflex in rats. Am J Physiol Renal Physiol (2006) 1.18
Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. J Urol (2010) 1.17
Simulation analysis of conduction block in myelinated axons induced by high-frequency biphasic rectangular pulses. IEEE Trans Biomed Eng (2006) 1.16
Role of opioid and metabotropic glutamate 5 receptors in pudendal inhibition of bladder overactivity in cats. J Urol (2012) 1.13
Mechanism of nerve conduction block induced by high-frequency biphasic electrical currents. IEEE Trans Biomed Eng (2006) 1.13
Roles of glutamatergic and serotonergic mechanisms in reflex control of the external urethral sphincter in urethane-anesthetized female rats. Am J Physiol Regul Integr Comp Physiol (2006) 1.12
Sensitization of pelvic afferent nerves in the in vitro rat urinary bladder-pelvic nerve preparation by purinergic agonists and cyclophosphamide pretreatment. Am J Physiol Renal Physiol (2008) 1.12
Protein kinase C epsilon contributes to basal and sensitizing responses of TRPV1 to capsaicin in rat dorsal root ganglion neurons. Eur J Neurosci (2008) 1.12
Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study. Mayo Clin Proc (2008) 1.11
Prolonged poststimulation inhibition of bladder activity induced by tibial nerve stimulation in cats. Am J Physiol Renal Physiol (2010) 1.11
Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J Urol (2003) 1.10
Response of external urethral sphincter to high frequency biphasic electrical stimulation of pudendal nerve. J Urol (2005) 1.10
Manganese superoxide dismutase gene therapy protects against irradiation-induced cystitis. Am J Physiol Renal Physiol (2002) 1.10
Abnormal excitability in capsaicin-responsive DRG neurons from cats with feline interstitial cystitis. Exp Neurol (2005) 1.10
Voiding reflex in chronic spinal cord injured cats induced by stimulating and blocking pudendal nerves. Neurourol Urodyn (2007) 1.09
Reactive oxygen species mediate detrusor overactivity via sensitization of afferent pathway in the bladder of anaesthetized rats. BJU Int (2007) 1.09
Irritation induced bladder overactivity is suppressed by tibial nerve stimulation in cats. J Urol (2011) 1.08
Brain switch for reflex micturition control detected by FMRI in rats. J Neurophysiol (2009) 1.07
Histological and electrical properties of rat dorsal root ganglion neurons innervating the lower urinary tract. J Neurosci (2003) 1.06
Post-stimulation inhibitory effect on reflex bladder activity induced by activation of somatic afferent nerves in the foot. J Urol (2011) 1.06
Protein kinase C is involved in neurokinin receptor modulation of N- and L-type Ca2+ channels in DRG neurons of the adult rat. J Neurophysiol (2003) 1.05
Role of spinal GABAA receptors in pudendal inhibition of nociceptive and nonnociceptive bladder reflexes in cats. Am J Physiol Renal Physiol (2014) 1.05
Involvement of metabotropic glutamate receptor 5 in pudendal inhibition of nociceptive bladder activity in cats. J Physiol (2011) 1.05
Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol (2008) 1.05
Targeting afferent hyperexcitability for therapy of the painful bladder syndrome. Urology (2002) 1.04
Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis. J Urol (2007) 1.03
Protein kinase C contributes to abnormal capsaicin responses in DRG neurons from cats with feline interstitial cystitis. Neurosci Lett (2005) 1.03
Detrusor overactivity induced by intravesical application of adenosine 5'-triphosphate under different delivery conditions in rats. Urology (2005) 1.02
Inhibitory control of the urinary bladder in the neonatal rat in vitro spinal cord-bladder preparation. Brain Res Dev Brain Res (2002) 1.02
Clinical and pathologic tumor size in renal cell carcinoma; difference, correlation, and analysis of the influencing factors. Urology (2002) 1.02
Functional analysis of active urethral closure mechanisms under sneeze induced stress condition in a rat model of birth trauma. J Urol (2006) 1.01
Neurokinins enhance excitability in capsaicin-responsive DRG neurons. Exp Neurol (2007) 1.01
Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Hum Gene Ther (2009) 1.01
Transdermal delivery of drugs for urologic applications: basic principles and applications. Urology (2006) 1.01
Plasticity of urinary bladder reflexes evoked by stimulation of pudendal afferent nerves after chronic spinal cord injury in cats. Exp Neurol (2010) 1.01
Bladder hyperactivity and increased excitability of bladder afferent neurons associated with reduced expression of Kv1.4 alpha-subunit in rats with cystitis. Am J Physiol Regul Integr Comp Physiol (2009) 1.00
Drug Insight: biological effects of botulinum toxin A in the lower urinary tract. Nat Clin Pract Urol (2008) 1.00
Influence of naloxone on inhibitory pudendal-to-bladder reflex in cats. Exp Neurol (2010) 1.00
Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency. Urology (2004) 0.99
KW-7158 [(2S)-(+)-3,3,3-trifluoro-2-hydroxy-2-methyl-N-(5,5,10-trioxo-4,10-dihydrothieno[3,2-c][1]benzothiepin-9-yl)propanamide] enhances A-type K+ currents in neurons of the dorsal root ganglion of the adult rat. J Pharmacol Exp Ther (2004) 0.99
Neural control of the female urethral and anal rhabdosphincters and pelvic floor muscles. Am J Physiol Regul Integr Comp Physiol (2010) 0.99
Botulinum neurotoxin serotype A suppresses neurotransmitter release from afferent as well as efferent nerves in the urinary bladder. Eur Urol (2012) 0.98
A model of intrinsic sphincteric deficiency in the rat: electrocauterization. Neurourol Urodyn (2004) 0.98
Multi-joint movement of the cat hindlimb evoked by microstimulation of the lumbosacral spinal cord. Exp Neurol (2003) 0.98
GABA receptor activation in the lumbosacral spinal cord decreases detrusor overactivity in spinal cord injured rats. J Urol (2008) 0.98
Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes (2004) 0.97
Safety evaluation of fospropofol for sedation during minor surgical procedures. J Clin Anesth (2010) 0.97